The myelosuppressive effect of linezolid among drug-resistant tuberculosis patients in Mongolia

被引：0
|
作者：
Baigabyl, Bolyskhan [1 ]
Jaalkhorol, Myadagmaa [2 ]
Tseden-Ish, Manaljav [3 ]
Dashtseren, Ichinnorov [3 ]
Tsogbadrakh, Odgerel [4 ]
机构：
[1] Natl Ctr Communicable Dis, Dept Pulm TB 2, TB Clin, Ulaanbaatar, Mongolia
[2] Mongolian Natl Univ Med Sci, Sch Publ Hlth, Dept Prevent Med, Ulaanbaatar, Mongolia
[3] Mongolian Natl Univ Med Sci, Dept Pulmonol & Allergy, Ulaanbaatar, Mongolia
[4] Mongolian Natl Univ Med Sci, Sch Med, Dept Hematol, Ulaanbaatar, Mongolia
来源：
RESPIROLOGY | 2023年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AO19-6
引用
收藏
页码：112 / 112
页数：1
相关论文
共 50 条
  • [31] Linezolid-Associated Optic Neuropathy in a Patient With Drug-Resistant Tuberculosis
    Han, Jinu
    Lee, Kyungsik
    Rhiu, Soolienah
    Lee, Jong Bok
    Han, Sueng Han
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2013, 33 (03) : 316 - 318
  • [32] Linezolid use for drug-resistant tuberculosis in Georgia: a retrospective cohort study
    Mikiashvilli, L.
    Kipiani, M.
    Schechter, M. C.
    Avaliani, Z.
    Kiria, N.
    Kempker, R. R.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2020, 24 (04) : 436 - 443
  • [33] Linezolid Population Pharmacokinetics in South African Adults with Drug-Resistant Tuberculosis
    Abdelwahab, Mahmoud Tareq
    Wasserman, Sean
    Brust, James C. M.
    Dheda, Keertan
    Wiesner, Lubbe
    Gandhi, Neel R.
    Warren, Robin M.
    Sirgel, Frederick A.
    Meintjes, Graeme
    Maartens, Gary
    Denti, Paolo
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (12)
  • [34] The Efficacy Of Linezolid For The Treatment Of Chronic Extensively Drug-Resistant Tuberculosis In Korea
    Lee, M.
    Jeong, I.
    Choi, H.
    Song, T.
    Chen, R.
    Joh, J.
    Han, S.
    Kim, Y.
    Cho, R.
    Via, L. E.
    Barry, C. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [35] Experiences in the introduction of bedaquiline pretomanid linezolid for drug-resistant tuberculosis in Kyrgyzstan
    Myrzaliev, B.
    Ahmatov, M.
    Duishekeeva, A.
    Kulzhabaeva, A.
    Kadyrov, A.
    Toktogonova, A.
    Abdulaeva, G.
    Wares, D. F.
    Mirtskhulava, V.
    Mbenga, M.
    Slyzkyi, A.
    Foraida, S.
    Diachenko, M.
    Juneja, S.
    Turdumambetova, G.
    Musaeva, A.
    Gebhard, A.
    JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES, 2024, 36
  • [36] The Knowledge, Attitude, and Practices Relating to Tuberculosis among Drug-Resistant Tuberculosis Patients
    Dzeyie, Kevisetuo Anthony
    Basu, Saurav
    Dikid, Tanzin
    INDIAN JOURNAL OF MEDICAL SPECIALITIES, 2019, 10 (02) : 76 - 78
  • [37] Drug-resistant Mycobacterium tuberculosis among new tuberculosis patients, Yangon, Myanmar
    Phyu, S
    Ti, T
    Jureen, R
    Hmun, T
    Myint, H
    Htun, A
    Grewal, HMS
    Bjorvatn, B
    EMERGING INFECTIOUS DISEASES, 2003, 9 (02) : 274 - 276
  • [38] Drug-resistant Mycobacterium tuberculosis among Nepalese patients at a tuberculosis referral center
    Chand, Arun Bahadur
    Basnet, Ajaya
    Maharjan, Bhagwan
    Rai, Ganesh
    Joshi, Yadav Prasad
    Bhatt, Lok Raj
    Sen, Bindu
    Rai, Shiba Kumar
    PLOS ONE, 2024, 19 (05):
  • [39] Linezolid Pharmacokinetics in South African Patients with Drug-Resistant Tuberculosis and a High Prevalence of HIV Coinfection
    Wasserman, Sean
    Denti, Paolo
    Brust, James C. M.
    Abdelwahab, Mahmoud
    Hlungulu, Siphokazi
    Wiesner, Lubbe
    Norman, Jennifer
    Sirgel, Frederick A.
    Warren, Robin M.
    Esmail, Aliasgar
    Dheda, Keertan
    Gandhi, Neel R.
    Meintjes, Graeme
    Maartens, Gary
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (03)
  • [40] Comparison of the Pharmacokinetics of Two Dosage Regimens of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis Patients
    Jan-Willem C. Alffenaar
    Richard van Altena
    Ilse M. Harmelink
    Patricia Filguera
    Esther Molenaar
    A. Mireille A. Wessels
    Dick van Soolingen
    Jos G. W. Kosterink
    Donald R. A. Uges
    Tjip S. van der Werf
    Clinical Pharmacokinetics, 2010, 49 : 559 - 565
12345